Overview Dividends

(CROX) Crocs - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2270461096

Clogs, Sandals, Sneakers, Slides, Boots

CROX EPS (Earnings per Share)

EPS (Earnings per Share) of CROX over the last years for every Quarter: "2020-09": 0.94, "2020-12": 1.06, "2021-03": 1.49, "2021-06": 2.23, "2021-09": 2.47, "2021-12": 2.15, "2022-03": 2.05, "2022-06": 3.24, "2022-09": 2.97, "2022-12": 2.65, "2023-03": 2.61, "2023-06": 3.59, "2023-09": 3.25, "2023-12": 2.58, "2024-03": 3.02, "2024-06": 4.01, "2024-09": 3.6, "2024-12": 2.52, "2025-03": 3, "2025-06": 4.23, "2025-09": 2.92,
EPS Growth (3Y CAGR): 3.59%
EPS Trend (3Y Correlation): 29.7%

CROX Revenue

Revenue of CROX over the last years for every Quarter: 2020-09: 361.736, 2020-12: 411.506, 2021-03: 460.098, 2021-06: 640.773, 2021-09: 625.919, 2021-12: 586.626, 2022-03: 660.148, 2022-06: 964.581, 2022-09: 985.094, 2022-12: 945.162, 2023-03: 884.166, 2023-06: 1072.367, 2023-09: 1045.717, 2023-12: 960.097, 2024-03: 938.633, 2024-06: 1111.502, 2024-09: 1062.2, 2024-12: 989.773, 2025-03: 937.333, 2025-06: 1149.373, 2025-09: 996.301,
Revenue Growth (3Y CAGR): 1.93%
Revenue Trend (3Y Correlation): 34.9%

Description: CROX Crocs November 06, 2025

Crocs, Inc. (NASDAQ:CROX) designs, manufactures, markets and distributes casual-lifestyle footwear and accessories for men, women and children under the Crocs and HEYDUDE brands. Its product slate spans clogs, sandals, platforms, wedges, boots, slides, flip-flops, sneakers, slippers and complementary items such as beads, straps, bags and socks, sold through a mix of wholesale partners, company-owned retail stores, e-commerce sites, third-party marketplaces and kiosk-in-store concepts.

Key recent metrics: FY 2024 revenue reached roughly $2.2 billion, with a gross margin of about 45% and direct-to-consumer sales growing ~18% YoY, driven largely by online traffic and a stronger HEYDUDE contribution. The global casual-footwear market is expanding at ~3% CAGR, while discretionary consumer spending remains sensitive to inflation and employment trends-both of which can materially affect Crocs’ top line.

For a deeper quantitative assessment, you might explore ValueRay’s CROX valuation dashboard to see how these drivers are reflected in the current price target.

CROX Stock Overview

Market Cap in USD 4,241m
Sub-Industry Footwear
IPO / Inception 2006-02-08

CROX Stock Ratings

Growth Rating -31.6%
Fundamental 54.5%
Dividend Rating -
Return 12m vs S&P 500 -32.1%
Analyst Rating 4.20 of 5

CROX Dividends

Currently no dividends paid

CROX Growth Ratios

Growth Correlation 3m -27.1%
Growth Correlation 12m -64%
Growth Correlation 5y 18.8%
CAGR 5y -5.48%
CAGR/Max DD 3y (Calmar Ratio) -0.10
CAGR/Mean DD 3y (Pain Ratio) -0.21
Sharpe Ratio 12m -1.65
Alpha -48.64
Beta 1.429
Volatility 49.00%
Current Volume 1460.4k
Average Volume 20d 1717.9k
Stop Loss 75.2 (-4.6%)
Signal 0.16

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (182.5m TTM) > 0 and > 6% of Revenue (6% = 244.4m TTM)
FCFTA 0.17 (>2.0%) and ΔFCFTA -3.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 6.86% (prev 7.31%; Δ -0.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.18 (>3.0%) and CFO 779.8m > Net Income 182.5m (YES >=105%, WARN >=100%)
Net Debt (233.4m) to EBITDA (95.3m) ratio: 2.45 <= 3.0 (WARN <= 3.5)
Current Ratio 1.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (55.2m) change vs 12m ago -7.28% (target <= -2.0% for YES)
Gross Margin 59.08% (prev 58.15%; Δ 0.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 90.38% (prev 86.41%; Δ 3.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.43 (EBITDA TTM 95.3m / Interest Expense TTM 180.9m) >= 6 (WARN >= 3)

Altman Z'' 4.29

(A) 0.06 = (Total Current Assets 971.2m - Total Current Liabilities 691.7m) / Total Assets 4.30b
(B) 0.79 = Retained Earnings (Balance) 3.38b / Total Assets 4.30b
(C) 0.02 = EBIT TTM 77.3m / Avg Total Assets 4.51b
(D) 1.14 = Book Value of Equity 3.33b / Total Liabilities 2.94b
Total Rating: 4.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 54.52

1. Piotroski 6.0pt = 1.0
2. FCF Yield 16.01% = 5.0
3. FCF Margin 17.59% = 4.40
4. Debt/Equity 0.28 = 2.46
5. Debt/Ebitda 2.45 = -0.86
6. ROIC - WACC (= -10.31)% = -12.50
7. RoE 11.08% = 0.92
8. Rev. Trend 34.92% = 2.62
9. EPS Trend 29.68% = 1.48

What is the price of CROX shares?

As of November 09, 2025, the stock is trading at USD 78.85 with a total of 1,460,351 shares traded.
Over the past week, the price has changed by -3.48%, over one month by +0.04%, over three months by +6.00% and over the past year by -22.59%.

Is Crocs a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Crocs is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 54.52 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CROX is around 65.90 USD . This means that CROX is currently overvalued and has a potential downside of -16.42%.

Is CROX a buy, sell or hold?

Crocs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CROX.
  • Strong Buy: 7
  • Buy: 4
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CROX price?

Issuer Target Up/Down from current
Wallstreet Target Price 89.5 13.5%
Analysts Target Price 89.5 13.5%
ValueRay Target Price 75.9 -3.7%

CROX Fundamental Data Overview November 02, 2025

Market Cap USD = 4.24b (4.24b USD * 1.0 USD.USD)
P/E Trailing = 28.3646
P/E Forward = 9.4697
P/S = 1.0413
P/B = 3.3129
P/EG = -31.83
Beta = 1.429
Revenue TTM = 4.07b USD
EBIT TTM = 77.3m USD
EBITDA TTM = 95.3m USD
Long Term Debt = 1.35b USD (from longTermDebt, last fiscal year)
Short Term Debt = 84.3m USD (from shortTermDebt, last quarter)
Debt = 387.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 233.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.47b USD (4.24b + Debt 387.4m - CCE 154.0m)
Interest Coverage Ratio = 0.43 (Ebit TTM 77.3m / Interest Expense TTM 180.9m)
FCF Yield = 16.01% (FCF TTM 716.2m / Enterprise Value 4.47b)
FCF Margin = 17.59% (FCF TTM 716.2m / Revenue TTM 4.07b)
Net Margin = 4.48% (Net Income TTM 182.5m / Revenue TTM 4.07b)
Gross Margin = 59.08% ((Revenue TTM 4.07b - Cost of Revenue TTM 1.67b) / Revenue TTM)
Gross Margin QoQ = 58.52% (prev 61.67%)
Tobins Q-Ratio = 1.04 (Enterprise Value 4.47b / Total Assets 4.30b)
Interest Expense / Debt = 28.99% (Interest Expense 112.3m / Debt 387.4m)
Taxrate = 23.02% (43.6m / 189.4m)
NOPAT = 59.5m (EBIT 77.3m * (1 - 23.02%))
Current Ratio = 1.40 (Total Current Assets 971.2m / Total Current Liabilities 691.7m)
Debt / Equity = 0.28 (Debt 387.4m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 2.45 (Net Debt 233.4m / EBITDA 95.3m)
Debt / FCF = 0.33 (Net Debt 233.4m / FCF TTM 716.2m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 182.5m / Total Assets 4.30b)
RoE = 11.08% (Net Income TTM 182.5m / Total Stockholder Equity 1.65b)
RoCE = 2.58% (EBIT 77.3m / Capital Employed (Equity 1.65b + L.T.Debt 1.35b))
RoIC = 1.89% (NOPAT 59.5m / Invested Capital 3.15b)
WACC = 12.20% (E(4.24b)/V(4.63b) * Re(11.28%) + D(387.4m)/V(4.63b) * Rd(28.99%) * (1-Tc(0.23)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.88%
[DCF Debug] Terminal Value 69.63% ; FCFE base≈805.8m ; Y1≈910.5m ; Y5≈1.23b
Fair Price DCF = 248.7 (DCF Value 12.91b / Shares Outstanding 51.9m; 5y FCF grow 15.10% → 3.0% )
EPS Correlation: 29.68 | EPS CAGR: 3.59% | SUE: 2.59 | # QB: 15
Revenue Correlation: 34.92 | Revenue CAGR: 1.93% | SUE: 1.95 | # QB: 1

Additional Sources for CROX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle